Astellas Pharma Inc (FRA:YPHA)
€ 11.3 -0.20 (-1.74%) Market Cap: 20.24 Bil Enterprise Value: 21.74 Bil PE Ratio: 13.71 PB Ratio: 2.18 GF Score: 82/100

Astellas Pharma Inc R&D Day Transcript

Mar 30, 2026 / 12:00 AM GMT
Release Date Price: €13.4


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

4503.T - Astellas Pharma Inc
Astellas Pharma Inc R&D Day
Mar 31, 2026 / 12:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for taking time out of your busy schedules to join us today for Astella's R&D Day.

I am Kato, Chief Communications and IR Officer, and I'll be serving as the moderator today. It is a pleasure to have you here.

Following our presentation, we will move on to the Q&A session. The presentation will be based on the presentation materials available on our website.

Simultaneous interpretation in Japanese and English will be provided throughout the event, including the Q&A session.

Please note that we cannot guarantee the accuracy of the simultaneous interpretation.

You can select your preferred language from the menu at the top of the Zoom screen.

If you select the original
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot